AI assistant
Denarius Metals — Interim / Quarterly Report 2025
Nov 14, 2025
44279_rns_2025-11-14_e1dd4912-6686-4b52-bd25-d17bb44cde7a.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
Denarius Metals Corp.
Interim Condensed Consolidated Financial Statements (Unaudited)
For the three and nine months ended September 30, 2025 and 2024
Denarius Metals Corp.
Interim Condensed Consolidated Statements of Financial Position
(Unaudited; Expressed in thousands of U.S. dollars)
| Notes | September 30, 2025 | December 31, 2024 | |
|---|---|---|---|
| ASSETS | |||
| Current | |||
| Cash and cash equivalents | $ 1,020 | $ 1,130 | |
| Cash in trust | 8b | - | 486 |
| Other receivables | 300 | 216 | |
| Inventories | 81 | - | |
| Prepaid expenses and deposits | 542 | 582 | |
| Deferred financing costs | 10 | 749 | - |
| 2,692 | 2,414 | ||
| Non-current | |||
| Mineral property, plant and equipment | 3 | 28,674 | 20,500 |
| Exploration and evaluation assets | 4 | 56,573 | 48,147 |
| Investment in joint venture | 5 | 11,321 | 9,992 |
| Advances to joint venture | 5 | 2,430 | - |
| Total assets | $ 101,690 | $ 81,053 | |
| LIABILITIES AND EQUITY | |||
| Current | |||
| Accounts payable and accrued liabilities | 6 | $ 3,974 | $ 3,210 |
| Short-term borrowings | 7 | 2,254 | 1,263 |
| Convertible Debentures | 8 | 45,763 | 29,486 |
| Current portion of NSR liability | 9 | 375 | 563 |
| Current portion of Zancudo Prepayment Facility | 10 | 1,125 | - |
| Current portion of lease obligations | 11 | 172 | 87 |
| Amount payable related to acquisition of joint venture | 5 | - | 259 |
| 53,663 | 34,868 | ||
| Non-current | |||
| Accounts payable and accrued liabilities | 6 | 1,177 | 1,451 |
| Zancudo NSR liability | 9 | 4,813 | 4,773 |
| Zancudo Prepayment Facility | 10 | 1,327 | - |
| Lease obligations | 11 | 169 | 21 |
| Other liabilities | 303 | 267 | |
| Total liabilities | 61,452 | 41,380 | |
| Equity | |||
| Share capital | 12b | 123,256 | 116,127 |
| Share purchase warrants | 12c | 18,006 | 12,577 |
| Contributed surplus | 12d | 5,366 | 4,743 |
| Accumulated other comprehensive loss | 997 | (7,308) | |
| Deficit | (107,387) | (86,466) | |
| Total equity | 40,238 | 39,673 | |
| Total liabilities and shareholders’ equity | $ 101,690 | $ 81,053 |
Basis of presentation and going concern
Subsequent events
(Note 2)
(Notes 8a, 8b and 10)
See accompanying notes to the interim condensed consolidated financial statements.
Denarius Metals Corp.
Interim Condensed Consolidated Statements of Operations and Comprehensive Loss
(Unaudited; Expressed in thousands of U.S. dollars, except share amounts)
| Notes | Three months ended September 30, | Nine months ended September 30, | |||
|---|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | ||
| Revenue | 14 | $ 456 | $ - | $ 505 | $ - |
| Costs and expenses | |||||
| Costs of sales | (349) | - | (384) | - | |
| General and administrative expenses | 16 | (1,180) | (991) | (3,602) | (3,143) |
| Share-based compensation | 12d | (321) | (26) | (608) | (275) |
| Finder's fee and other costs associated with acquisition of joint venture investment | 5 | - | (63) | - | (835) |
| Loss before the following | (1,394) | (1,080) | (4,089) | (4,253) | |
| Other income (expense) | |||||
| Finance income | 36 | 12 | 73 | 149 | |
| Finance costs | 15 | (387) | (1,823) | (2,454) | (5,524) |
| Loss on financial instruments | 8 | (10,307) | (6,880) | (14,399) | (3,165) |
| (Loss) gain on settlement of interest on Convertible Debentures | 8 | (39) | - | 15 | - |
| Gains on modification of amount payable related to acquisition of joint venture investment | 5 | - | - | - | 278 |
| Loss on settlement of Zancudo NSR Minimum Payment Adjustment | 9 | - | - | (1,036) | - |
| Equity share of income (loss) in joint venture | 5 | 67 | (26) | 3 | 66 |
| Foreign exchange gain | 358 | 331 | 966 | 395 | |
| Net loss | (11,666) | (9,466) | (20,921) | (12,054) | |
| Attributed to: | |||||
| Shareholders of the Company | (11,666) | (9,597) | (20,921) | (12,071) | |
| Non-controlling interest | - | 131 | - | 17 | |
| (11,666) | (9,466) | (20,921) | (12,054) | ||
| Other comprehensive (loss) income: | |||||
| Items that will not be reclassified to profit in subsequent periods: | |||||
| Unrealized loss on Convertible Debentures due to changes in credit risk (nil tax effect) | (290) | (21) | (252) | (185) | |
| Items that may be reclassified to profit in subsequent periods: | |||||
| Foreign currency translation adjustment (nil tax effect) | 1,294 | 1,255 | 8,557 | (570) | |
| Comprehensive loss | $ (10,662) | $ (8,232) | $ (12,616) | $ (12,809) | |
| Basic and diluted loss per share | $ (0.09) | $ (0.14) | $ (0.19) | $ (0.18) | |
| Weighted average number of common shares outstanding | 123,021,658 | 70,527,028 | 109,602,842 | 66,116,287 |
See accompanying notes to the interim condensed consolidated financial statements.
Denarius Metals Corp.
Interim Condensed Consolidated Statements of Equity
(Unaudited; Expressed in thousands of U.S. dollars)
| | Notes | Nine months ended
September 30, | |
| --- | --- | --- | --- |
| | | 2025 | 2024 |
| Share capital | | | |
| Balance, beginning of period | | $ 116,127 | $ 103,233 |
| Shares issued on conversion of Convertible Debentures Series 1 | 8a | 40 | 1,948 |
| Shares issued on conversion of Convertible Debentures Series 2 | 8b | 25 | - |
| Shares issued to settle interest on Convertible Debentures | 8 | 727 | - |
| Share issue costs related to settlements of interest on Convertible Debentures | 8 | (12) | - |
| Shares issued to settle Zancudo NSR Minimum Payment Adjustment | 9 | 1,057 | - |
| Share issue costs related to settlement of Zancudo NSR Minimum Payment Adjustment | 9 | (7) | - |
| Shares issued in 2025 Private Placement | 12b | 2,750 | - |
| Share issue costs related to 2025 Private Placement | 12b | (74) | - |
| Shares issued in LIFE Offering | 12b | 2,837 | - |
| Share issue costs related to LIFE Offering | 12b | (414) | - |
| Shares issued in 2024 Private Placement | 12b | - | 2,785 |
| Share issue costs related to 2024 Private Placement | 12b | - | (34) |
| Total transaction costs settled in shares | 12b | 95 | - |
| Exercise of options | 12d | 29 | - |
| Exercise of warrants | 12c | 76 | 1,653 |
| Balance, end of period | | 123,256 | 109,585 |
| Share purchase warrants | | | |
| Balance, beginning of period | | 12,577 | 11,022 |
| Zancudo NSR Minimum Payment Adjustment Warrants issued | 9 | 729 | - |
| Zancudo NSR Minimum Payment Adjustment Warrants issue costs | 9 | (4) | - |
| Zancudo Prepayment Facility warrants issued | 10 | 927 | - |
| 2025 Private Placement Warrants issued | 12b | 1,836 | - |
| 2025 Private Placement Warrants issue costs | 12b | (50) | - |
| LIFE Offering Warrants issued | 12b | 2,080 | - |
| LIFE Offering Warrants issue costs | 12b | (303) | - |
| LIFE Offering Broker Warrants issued | 12b | 229 | - |
| Convertible Debenture Warrants issued | | - | 1,274 |
| Convertible Debenture Warrants issue costs | | - | (41) |
| Exercise of warrants | 12c | (15) | (312) |
| Balance, end of period | | 18,006 | 11,943 |
| Contributed surplus | | | |
| Balance, beginning of period | | 4,743 | 4,408 |
| Exercise of options | 12c | (10) | - |
| Total transaction costs settled in shares | 12b | (95) | - |
| Share-based compensation | 12d | 728 | 351 |
| Balance, end of period | | 5,366 | 4,759 |
| Accumulated other comprehensive loss | | | |
| Balance, beginning of period | | (7,308) | (2,872) |
| Unrealized loss on Convertible Debentures due to changes in credit risk (nil tax effect) | 8 | (252) | (185) |
| Foreign currency translation adjustment | | 8,557 | (570) |
| Balance, end of period | | 997 | (3,627) |
| Deficit | | | |
| Balance, beginning of period | | (86,466) | (79,425) |
| Net loss attributable to shareholders of the Company | | (20,921) | (12,071) |
| Contributions to non-controlling interest in EMI | | - | (368) |
| Balance, end of period | | (107,387) | (91,864) |
| Non-Controlling Interest | | | |
| Balance, beginning of period | | - | 2,315 |
| Contributions to non-controlling interest in EMI | | - | 368 |
| Net loss attributable to non-controlling interest | | - | 17 |
| Balance, end of period | | - | 2,700 |
| Total equity | | $ 40,238 | $ 33,496 |
See accompanying notes to the interim condensed consolidated financial statements.
Denarius Metals Corp.
Interim Condensed Consolidated Statements of Cash Flows
(Unaudited; Expressed in thousands of U.S. dollars)
| | Notes | Nine months ended
September 30, | |
| --- | --- | --- | --- |
| | | 2025 | 2024 |
| Operating Activities | | | |
| Net loss | | $ (20,921) | $ (12,054) |
| Adjusted for the following items: | | | |
| Amortization | 3 | 165 | 160 |
| Share-based compensation | 12d | 608 | 275 |
| Finance costs | 15 | 2,454 | 5,524 |
| Loss on financial instruments | 8 | 14,399 | 3,165 |
| Gain on settlement of interest on Convertible Debentures | 8 | (15) | - |
| Gains on modification of amount payable related to acquisition of joint venture | | - | (278) |
| Loss on settlement of Zancudo NSR Minimum Payment Adjustment | 9 | 1,036 | - |
| Equity share of income in joint venture | 5 | (3) | (66) |
| Foreign exchange gain | | (966) | (395) |
| Changes in non-cash working capital items: | | | |
| Other receivables | | (85) | 380 |
| Inventories | | (76) | - |
| Prepaid expenses and deposits | | 94 | (20) |
| Accounts payable and accrued liabilities | | 147 | 20 |
| Net cash used in operating activities | | (3,163) | (3,289) |
| Investing Activities | | | |
| Additions to mineral property, plant and equipment | 3 | (3,102) | (7,108) |
| Additions to exploration and evaluation assets | 4 | (2,165) | (2,357) |
| Payments related to acquisition of CRI assets | | (177) | (77) |
| Payments related to acquisition of joint venture | 5 | (263) | (8,129) |
| Advances to joint venture | 5 | (2,293) | - |
| Capital contributions to joint venture | 5 | - | (750) |
| Deferred acquisition costs | | - | (66) |
| Net cash used in investing activities | | (8,000) | (18,487) |
| Financing Activities | | | |
| Proceeds from Zancudo Prepayment Facility | 10 | 2,500 | - |
| Zancudo Prepayment Facility financing costs | 10 | (104) | - |
| Proceeds from 2025 Private Placement | 12b | 3,522 | - |
| 2025 Private Placement issue costs | 12b | (124) | - |
| Proceeds from LIFE Offering | 12b | 4,917 | - |
| LIFE Offering transaction costs | 12b | (488) | - |
| Proceeds from 2024 Private Placement | 12b | - | 2,785 |
| 2024 Private Placement issue costs | 12b | - | (34) |
| Other financing costs | | (64) | - |
| Proceeds from sale of Zancudo NSR | 9 | - | 5,000 |
| Zancudo NSR transaction costs | 9 | - | (265) |
| Share issue costs related to settlement of Zancudo NSR Minimum Payment Adjustment | 9 | (11) | - |
| Share issue costs related to settlements of interest on Convertible Debentures | 7 | (12) | - |
| Increase in short-term borrowings | 7 | 1,871 | - |
| Proceeds from issuance of 2024 Convertible Debenture Units | 8b | - | 10,094 |
| 2024 Convertible Debenture Units issue costs | 8b | - | (344) |
| Change in cash in trust for interest on Convertible Debentures | | 494 | 493 |
| Convertible Debentures consent solicitation costs paid | | (77) | - |
| Interest paid | | (1,342) | (1,734) |
| Decrease in other liabilities | | - | (23) |
| Payment of lease obligations | 11 | (175) | (208) |
| Exercise of options | | 19 | - |
| Exercise of warrants | | 61 | 1,341 |
| Net cash provided by financing activities | | 10,987 | 17,105 |
| Impact of foreign exchange rate changes on cash and cash equivalents | | 66 | (161) |
| Decrease in cash and cash equivalents | | (110) | (4,832) |
| Cash and cash equivalents, beginning of period | | 1,130 | 7,628 |
| Cash and cash equivalents, end of period | | $ 1,020 | $ 2,796 |
See accompanying notes to the interim condensed consolidated financial statements.
Denarius Metals Corp.
Notes to the Interim Condensed Consolidated Financial Statements
September 30, 2025
(Unaudited; Tabular amounts expressed in thousands of U.S. dollars unless otherwise noted)
1. NATURE OF OPERATIONS
Denarius Metals Corp. (the "Company") is a company incorporated under the laws of the Province of British Columbia, Canada. The Company's head office is located in Toronto, Canada. The Company and its wholly-owned subsidiaries are engaged in the acquisition, exploration, development and operation of mineral properties, primarily in Colombia and Spain. The Company's common shares are listed on Cboe Canada under the symbol "DMET" and also trade on the OTCQX Market in the United States under the symbol "DNRSF".
2. BASIS OF PRESENTATION AND GOING CONCERN
These interim financial statements have been prepared in accordance with International Accounting Standards ("IAS") 34, Interim Financial Reporting, under IFRS Accounting Standards ("IFRS") as issued by the International Accounting Standards Board ("IASB").
The interim financial statements have been prepared following the same accounting policies and methods of computation as the audited consolidated financial statements for the fiscal year ended December 31, 2024, except as disclosed herein.
The interim financial statements do not include all the disclosures included in the annual audited consolidated financial statements and accordingly should be read in conjunction with the annual audited consolidated financial statements and the notes thereto for the year ended December 31, 2024. These interim financial statements were approved by the Audit Committee of the Company for issue on November 14, 2025.
The interim financial statements have been prepared under the historical cost basis, except for certain financial assets and liabilities which are measured at fair value, and are presented in U.S. dollars, rounded to the nearest thousand except when otherwise indicated.
The interim financial statements have been prepared on a going concern basis assuming that the Company will be able to realize its assets and discharge its liabilities in the normal course of business as they come due in the foreseeable future.
During the nine months ended September 30, 2025, the Company reported a net loss of $20.9 million and net cash used in operating activities of $3.2 million. As at September 30, 2025, the Company has cash and cash equivalents of $1.0 million and a working capital deficiency of $51.0 million. The working capital deficiency includes $45.8 million for the Convertible Debentures which are not repayable in cash within the next 12 months. In April 2025, the Company commenced mining operations at its Zancudo Project. While the Company is ramping up its production, it will require additional sources of capital to fund ongoing operational requirements and planned exploration, development and capital expenditures related to its mineral property and E&E assets. To continue as a going concern, the Company must generate sufficient operating cash flow to fund these requirements or secure new funding. There can be no assurance that these initiatives will be successful. These material uncertainties cast significant doubt as to the ability of the Company to meet its business plan and obligations as they come due and, accordingly, the appropriateness of the use of accounting principles applicable to a going concern.
These financial statements do not include adjustments to the recoverability and classifications of recorded assets and liabilities and related expenses that might be necessary should the Company be unable to continue as a going concern. Such adjustments could be material.
The recoverability of the amounts shown for mineral properties is dependent on the existence and economic extraction of resources, the capacity to obtain financing to complete the development of such resources, the ability to obtain the necessary licenses and permits, stability or increases in future commodity prices, and the success of future operations or dispositions of the mineral properties.
Consolidation
These financial statements comprise the financial results of the Company including its subsidiaries. Details regarding the Company and its principal subsidiaries, all of which have a December 31 year end, are summarized in the following table:
Page | 6
Denarius Metals Corp.
Notes to the Interim Condensed Consolidated Financial Statements
September 30, 2025
(Unaudited; Tabular amounts expressed in thousands of U.S. dollars unless otherwise noted)
| Entity | Property/ function | Registered | Functional currency^{(1)} | Interest as at September 30, 2025 | December 31, 2024 |
|---|---|---|---|---|---|
| Denarius Metals Corp. | Corporate | Canada | CA | - | - |
| Alto Minerals S.L.U. ("Alto") | Lomero Project | Spain | EUR | 100% | 100% |
| Europa Metals Iberia S.L. ("EMI") | Toral Project | Spain | EUR | 100% | 100% |
| Zancudo Metals Sucursal Colombia ("Zancudo") | Zancudo Project | Colombia | COP | 100% | 100% |
| Emerene Corporation S.A. ("Emerene") | Phosphates Project | Colombia | COP | 100% | 100% |
(1) "CA= Canadian dollar", "USD" = U.S. dollar; "COP" = Colombian peso, "EUR" = Euro
Intercompany transactions, balances and unrealized gains and losses on transactions between group companies are eliminated.
The consolidated financial statements also include the Company's 21% equity interest (December 31, 2024 – 21%) in Rio Narcea Recursos, S.A. ("RNR"), as outlined in Note 5. The investment in the RNR is accounted for using the equity method.
Inventories
Stockpiled ore is recorded at the lower of weighted average cost and net realizable value ("NRV"). Stockpiled ore inventory represents ore that has been extracted from the mine and is available for further processing. The cost of stockpiled ore inventory is derived from the costs incurred up to the point of stockpiling the ore and is removed at the weighted average cost as ore is processed.
Materials and supplies inventories are valued at the lower of cost and NRV, where cost is based on a first in, first out basis. NRV is the estimated selling price less applicable selling expenses and estimated costs to complete production.
Revenue recognition
Revenue from the sale of gold and silver is recognized when control has been transferred to the customer, which is considered to occur when products have been delivered to the location specified by the customer and the risks of loss have been passed to the customer. Revenue is measured at an amount reflecting the consideration the Company expects to receive in exchange for the product.
New accounting standards issued but not effective
IFRS 18 – Presentation and Disclosure in Financial Statements
On April 9, 2024, the IASB issued IFRS 18 Presentation and Disclosure in the Financial Statements ("IFRS 18") replacing IAS 1. IFRS 18 introduces categories and defined subtotals in the statement of profit or loss, disclosures on management-defined performance measures, and requirements to improve the aggregation and disaggregation of information in the financial statements. As a result of IFRS 18, amendments to IAS 7 Statement of Cash Flows were also issued to require that entities use the operating profit subtotal as the starting point for the indirect method of reporting cash flows from operating activities and also to remove presentation alternatives for interest and dividends paid and received. Similarly, amendments to IAS 33 Earnings per Share were issued to permit disclosure of additional earnings per share figures using any other component of the statement of profit or loss, provided the numerator is a total or subtotal defined under IFRS 18. IFRS 18 is effective for annual reporting periods beginning on or after January 1, 2027, and is to be applied retrospectively, with early adoption permitted. The Company is currently assessing the impact of the standard on its financial statements.
Page | 7
Denarius Metals Corp.
Notes to the Interim Condensed Consolidated Financial Statements
September 30, 2025
(Unaudited; Tabular amounts expressed in thousands of U.S. dollars unless otherwise noted)
- MINERAL PROPERTY, PLANT AND EQUIPMENT
| Mineral property | Construction in progress | Plant and equipment | Leasehold improvements | ROU Asset | Total | |
|---|---|---|---|---|---|---|
| Nine months ended September 30, 2025 | ||||||
| Opening net book value | $ 8,285 | $ 10,934 | $ 1,089 | $ 92 | $ 100 | $ 20,500 |
| Additions | 2,249 | 865 | 12 | (15) | 369 | 3,480 |
| Transfer | - | (473) | 473 | - | - | - |
| Capitalized borrowing costs (Note 15) | 1,817 | - | - | - | - | 1,817 |
| Share-based compensation | 105 | - | - | - | - | 105 |
| Depreciation and amortization | 27 | - | (70) | (6) | (156) | (205) |
| Exchange difference | 1,316 | 1,455 | 178 | 10 | 18 | 2,977 |
| Closing net book value | $ 13,799 | $ 12,781 | $ 1,682 | $ 81 | $ 331 | $ 28,674 |
| As at September 30, 2025 | ||||||
| Cost | $ 13,799 | $ 12,781 | $ 1,904 | $ 117 | $ 457 | $ 29,058 |
| Accumulated depreciation and amortization | - | - | (222) | (36) | (126) | (384) |
| Net book value | $ 13,799 | $ 12,781 | $ 1,682 | $ 81 | $ 331 | $ 28,674 |
| Year ended December 31, 2024 | ||||||
| Opening net book value | $ 2,740 | $ 4,307 | $ 949 | $ 110 | $ 356 | $ 8,462 |
| Acquisition of CRI assets | - | - | 291 | - | - | 291 |
| Additions | 4,033 | 7,794 | 36 | - | 1 | 11,864 |
| Capitalized borrowing costs (Note 15) | 2,202 | - | - | - | - | 2,202 |
| Share-based compensation | 37 | - | - | - | - | 37 |
| Depreciation and amortization | 21 | - | (65) | (10) | (237) | (291) |
| Exchange difference | (748) | (1,167) | (122) | (8) | (20) | (2,065) |
| Closing net book value | $ 8,285 | $ 10,934 | $ 1,089 | $ 92 | $ 100 | $ 20,500 |
| As at December 31, 2024 | ||||||
| Cost | $ 8,285 | $ 10,934 | $ 1,220 | $ 121 | $ 607 | $ 21,167 |
| Accumulated depreciation and amortization | - | - | (131) | (29) | (507) | (667) |
| Net book value | $ 8,285 | $ 10,934 | $ 1,089 | $ 92 | $ 100 | $ 20,500 |
A summary of the net book value is as follows:
| Mineral property | Construction in progress | Plant and equipment | Leasehold improvements | ROU Asset | Total | |
|---|---|---|---|---|---|---|
| As at September 30, 2025 | ||||||
| Zancudo Project | $ 13,799 | $ 12,781 | $ 1,173 | $ - | $ - | $ 27,753 |
| Phosphates Project | - | - | 51 | - | - | 51 |
| Lomero Project | - | - | 458 | 81 | 331 | 870 |
| Net book value | $ 13,799 | $ 12,781 | $ 1,682 | $ 81 | $ 331 | $ 28,674 |
Denarius Metals Corp.
Notes to the Interim Condensed Consolidated Financial Statements
September 30, 2025
(Unaudited; Tabular amounts expressed in thousands of U.S. dollars unless otherwise noted)
| Mineral property | Construction in progress | Plant and equipment | Leasehold improvements | ROU Asset | Total | |
|---|---|---|---|---|---|---|
| As at December 31, 2024 | ||||||
| Zancudo Project | $ 8,285 | $ 10,934 | $ 601 | $ - | $ - | $ 19,820 |
| Phosphates Project | - | - | 45 | - | - | 45 |
| Lomero Project | - | - | 443 | 92 | 68 | 603 |
| Corporate | - | - | - | - | 32 | 32 |
| Net book value | $ 8,285 | $ 10,934 | $ 1,089 | $ 92 | $ 100 | $ 20,500 |
a) As at September 30, 2025, accounts payable and accrued liabilities (Note 6) includes $3.8 million related to expenditures on plant and equipment and acquisition of the CRI assets (December 31, 2024 - $3.5 million).
b) Zancudo Project
The Company owns a 100% interest in the Zancudo Project located in the municipality of Titiribi, in the mining district of Antioquia, Colombia. The Zancudo Project is subject to a total of 3.5% net smelter royalty ("NSR") on future production from the project, payable in cash, including a 3% NSR sold in March 2024 to arm's length third parties for which the Company received cash proceeds totaling $5.0 million (Note 9).
- EXPLORATION AND EVALUATION ASSETS
| Phosphates | Lomero | Toral | Total | |
|---|---|---|---|---|
| Nine months ended September 30, 2025 | ||||
| Opening net book value | $ 1,040 | $ 39,642 | $ 7,465 | $ 48,147 |
| Additions | - | 1,395 | 520 | 1,915 |
| Share-based compensation | - | 15 | - | 15 |
| Depreciation and amortization capitalized | - | 40 | - | 40 |
| Exchange difference | 136 | 5,361 | 959 | 6,456 |
| Closing net book value | $ 1,176 | $ 46,453 | $ 8,944 | $ 56,573 |
| Year ended December 31, 2024 | ||||
| Opening net book value | $ 1,200 | $ 37,261 | $ 7,120 | $ 45,581 |
| Acquisition of CRI assets | - | 2,439 | - | 2,439 |
| Additions | - | 2,319 | 792 | 3,111 |
| Depreciation and amortization capitalized | - | 85 | - | 85 |
| Share-based compensation | - | 39 | - | 39 |
| Exchange difference | (160) | (2,501) | (447) | (3,108) |
| Closing net book value | $ 1,040 | $ 39,642 | $ 7,465 | $ 48,147 |
a) As at September 30, 2025, accounts payable and accrued liabilities (Note 6) includes $0.3 million related to expenditures on E&E assets (December 31, 2024 - $0.5 million).
b) Phosphates Project, Colombia
The Company owns 100% of the issued and outstanding shares of Emerene Corporation S.A. ("Emerene"), a Panamanian company which owns several phosphorite mining rights in Boyacá, Colombia (the "Phosphates Project").
c) Lomero Project
The Company owns a 100% interest in the Lomero Project, including the Rubia Investigation Permit which covers the areas occupied by the former Lomero-Poyatos Concessions and the mine within them and the adjacent Palomarejo Investigation Permit, both located in the Iberian Pyrite Belt in southern Spain. The Lomero Project is subject to a 2% NSR on production from the project, payable in cash. In September, 2025, the Company was granted the exploration permit for the Cruzadillo claims (the "Cruzadillo Investigation Permit") which are located less than 1 km from the Rubia and Palomarejo Investigation Permits.
Page | 9
Denarius Metals Corp.
Notes to the Interim Condensed Consolidated Financial Statements
September 30, 2025
(Unaudited; Tabular amounts expressed in thousands of U.S. dollars unless otherwise noted)
d) Toral Project
In November 2024, the Company completed the acquisition of 100% of the issued and outstanding shares of EMI (the "EMI Acquisition") from Europa Metals Ltd. ("Europa"). EMI holds the Toral Zn-Pb-Ag Project (the "Toral Project"), Leon Province, Northern Spain. The Company was carrying out an exploration program pursuant to an option agreement entered into with Europa in November 2022 that was cancelled on closing of the EMI Acquisition. The Toral Project is subject to a 1% NSR on any future production of minerals, payable in cash.
5. INVESTMENT IN RIO NARCEA RECURSOS, S.A. JOINT VENTURE
The Company has a 21% interest in RNR, which owns a 5,000 tonnes per day processing plant and has the rights to exploit the historic producing Aguablanca nickel-copper mine located in Monesterio, Extremadura, Spain.
The Company determined that is has joint control over RNR and therefore accounts for its 21% interest in RNR as an investment in joint venture using the equity method. The Company is responsible for arranging the financing on behalf of RNR for the capital required to restart the Aguablanca Project and will be obligated to pay a EUR 2 million penalty to the RNR Shareholder Group if the financing does not commence within 12 months of RNR having all the required permits, including the pending Water Concession, for the reactivation of the Aguablanca Project. During the nine months ended September 30, 2025, the Company made advances amounting to approximately $2.3 million to fund RNR's expenditures while it arranges the financing on behalf of RNR. The advances to the joint venture bear interest at a rate equivalent to the quarterly Euribor + 2.5%. Repayment of the advances by the joint venture to the Company will be made over a maximum period of five years following the start of operations at the Aguablanca Project.
The following tables summarize the consolidated financial information of RNR on a 100% basis, taking into account adjustments made by the Company for equity accounting purposes and fair value adjustments, on each of September 30, 2025 and December 31, 2024:
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| Total current assets | $ 1,251 | $ 1,963 |
| Total non-current assets | 76,396 | 65,780 |
| Total current liabilities | (9,073) | (7,501) |
| Total non-current liabilities | (14,663) | (12,662) |
| Total net assets | $ 53,911 | $ 47,580 |
| Nine Months Ended September 30, 2025 | Nine Months Ended September 30, 2024 | |
| Revenue | $ - | $ - |
| Net income | 10 | 136 |
| Other comprehensive income | - | - |
Reconciliation of RNR's net assets to the carrying value of the Company's investment in the RNR joint venture is as follows:
| Net assets of RNR at January 1, 2024 | 48,118 |
|---|---|
| Capital contributions for the year ended December 31, 2024 | 2,801 |
| Net loss for the year ended December 31, 2024 | (298) |
| Exchange difference | (3,041) |
| Net assets of RNR at December 31, 2024 | 47,580 |
| Net income for the nine months ended September 30, 2025 | 10 |
| Exchange difference | 6,321 |
| Net assets of RNR at September 30, 2025 | 53,911 |
| Equity interest | 21% |
| Investment in joint venture at September 30, 2025 | $ 11,321 |
Denarius Metals Corp.
Notes to the Interim Condensed Consolidated Financial Statements
September 30, 2025
(Unaudited; Tabular amounts expressed in thousands of U.S. dollars unless otherwise noted)
A summary of the changes in the investment in the joint venture is as follows:
| Amount | |
|---|---|
| As at January 1, 2024 | $ 24,059 |
| Capital contributions to RNR | 1,422 |
| Equity share of loss in RNR | (149) |
| Reduction of investment on disposal of 29% interest in RNR | (13,893) |
| Exchange difference | (1,447) |
| As at December 31, 2024 | 9,992 |
| Equity share of income in RNR | 3 |
| Exchange difference | 1,326 |
| As at September 30, 2025 | $ 11,321 |
The following table summarizes the changes in the amount payable related to the acquisition of the investment in RNR:
| Amount | |
|---|---|
| As at January 1, 2024 | $ 21,708 |
| Instalments paid (EUR 7.75 million) | (8,396) |
| Accretion (Note 15) | 3,351 |
| Gains on modifications of debt | (278) |
| Reduction of investment on disposal of 29% interest in RNR | (15,118) |
| Exchange difference | (1,008) |
| As at December 31, 2024 | 259 |
| Final instalment paid (EUR 0.25 million) | (263) |
| Exchange difference | 4 |
| As at September 30, 2025 | $ - |
6. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| Related to operating, general and administrative expenses | $ 775 | $ 684 |
| Related to expenditures for mineral property, plant and equipment (Note 3) | 2,517 | 2,322 |
| Related to expenditures for E&E assets (Note 4) | 307 | 474 |
| Related to acquisition of CRI assets, including transaction costs | 1,307 | 1,181 |
| Interest on Convertible Debentures (Notes 8a, 8b) | 245 | - |
| Total accounts payable and accrued liabilities | 5,151 | 4,661 |
| Non-current portion related to expenditures for mineral property, plant and equipment | (705) | (856) |
| Non-current portion related to acquisition of CRI assets | (472) | (595) |
| Current portion | $ 3,974 | $ 3,210 |
Denarius Metals Corp.
Notes to the Interim Condensed Consolidated Financial Statements
September 30, 2025
(Unaudited; Tabular amounts expressed in thousands of U.S. dollars unless otherwise noted)
7. SHORT-TERM BORROWINGS
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| Brockville Promissory Notes | $ 311 | $ 487 |
| Zenk Promissory Note | 625 | - |
| Other short-term borrowing facilities | 1,318 | 776 |
| Current portion | $ 2,254 | $ 1,263 |
Related Party Borrowings
In December 2024, Brockville International Holdings Ltd. ("Brockville"), an entity controlled by the Executive Chairman of the Company, advanced CA$0.7 million (equivalent to $0.5 million) to the Company by way of an unsecured promissory note ("Brockville Promissory Note") maturing June 30, 2025. The proceeds were used by the Company toward the funding for the remaining acquisition payments totalling EUR 0.5 million owing to the RNR Shareholder Group (Note 5) in connection with the Company's acquisition of a 21% equity interest in RNR. In January and February 2025, the Company received two additional advances from Brockville totalling CA$0.8 million (equivalent to approximately $0.6 million) on the same terms and conditions as the first Brockville Promissory Note. The proceeds of these additional Brockville Promissory Notes were used by the Company to fund an advance to RNR and for general corporate purposes. These Brockville Promissory Notes were settled in March 2025 in conjunction with the Company's non-brokered private placement (Note 12b). Interest on the Brockville Promissory Notes was incurred at a rate of 12% per annum.
In May 2025, Brockville advanced CA$0.4 million (equivalent to $0.3 million) to the Company by way of an additional unsecured promissory note due on the same terms and conditions as the previous Brockville Promissory Notes. Proceeds were used to fund certain expenditures at the Zancudo Project while it awaited receipt of the second advance under the Zancudo Prepayment Facility (Note 10). In October 2025, the maturity date for this Brockville Promissory Note was extended to November 30, 2025.
The Company also received an advance in May 2025 of $0.6 million from Zenk Capital Private Fund, an entity controlled by the Chief Executive Officer of the Company, by way of an unsecured promissory note due November 30, 2025 to fund the payment of certain accounts payable at the Lomero Project and to fund an advance to RNR. Interest on the Zenk Promissory Notes is being incurred at a rate of 12% per annum.
These transactions, occurring in the normal course of operations, are measured at the exchange amount, which is the amount of consideration established and agreed to by the related parties.
Other Short-Term Borrowings
As at September 30, 2025, the Company has borrowings under other short-term facilities with third parties totalling approximately $1.3 million (December 31, 2024 - $0.8 million) to fund expenditures related to its Zancudo Project while it awaits receipt of funds under the Zancudo Prepayment Facility. These borrowings have a term of 90 days. The Company is required to pay a facility fee of 1% upon receipt of the funds and to make monthly interest payments at a rate of 2.1%.
8. CONVERTIBLE DEBENTURES
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| Convertible Debentures Series 1 (Note 8a) | $ 30,361 | $ 19,379 |
| Convertible Debentures Series 2 (Note 8b) | 15,402 | 10,107 |
| Total Convertible Debentures | $ 45,763 | $ 29,486 |
Denarius Metals Corp.
Notes to the Interim Condensed Consolidated Financial Statements
September 30, 2025
(Unaudited; Tabular amounts expressed in thousands of U.S. dollars unless otherwise noted)
a) Convertible Debentures Series 1
| Number | Amount | |
|---|---|---|
| As at January 1, 2024 | 20,632,000 | $ 22,653 |
| Conversions | (1,380,000) | (1,970) |
| Change in FVTPL | - | 3,124 |
| Change in FVOCI due to changes in credit risk | - | 181 |
| Gain on modification of terms | - | (2,958) |
| Issuance of consent fee debentures | 304,000 | 302 |
| Exchange difference | - | (1,953) |
| As at December 31, 2024 | 19,556,000 | $ 19,379 |
| Conversions | (35,000) | (40) |
| Change in FVTPL | - | 9,675 |
| Change in FVOCI due to changes in credit risk | - | 236 |
| Issuance of consent fee debentures | 365,560 | 495 |
| Exchange difference | - | 616 |
| As at September 30, 2025 | 19,886,560 | $ 30,361 |
In October 2023, the Company closed a private placement in two tranches issuing a total of CA$20.6 million aggregate principal amount (equivalent to approximately $14.9 million) of senior unsecured convertible debentures (the "Convertible Debentures Series 1"). The Convertible Debentures Series 1 are listed on Cboe Canada under the symbol "DMET.DB".
The Convertible Debentures Series 1 are non-callable and mature and become payable in full at maturity on October 19, 2029, unless otherwise converted, prepaid or accelerated in accordance with their terms. The Convertible Debentures Series 1 bear interest at 12% per annum, paid monthly in equal installments in cash.
Commencing January 31, 2026, and at the end of each quarter thereafter, the Company will pay a gold premium in cash on the principal amount of the Convertible Debentures Series 1. The gold premium will be calculated as a percentage equal to 25% of (i) the amount, if any, by which the London P.M. Gold Fix on the quarterly measurement date exceeds $1,800 per ounce (the "2023 Floor Price") divided by (ii) the 2023 Floor Price.
On June 18, 2025, the Convertible Debentures Series 1 were amended through a consent solicitation process to (i) enable the Company to issue common shares rather than cash to settle the monthly interest payments from June 30, 2025 to May 31, 2026, inclusive; (ii) enable the Company to issue common shares rather than cash to settle the Gold Premium Payments, if any, payable on each January 31, 2026 and April 30, 2026 and (iii) implement a maximum amount of $4,000 per ounce for the London P.M. Gold Fix in the Gold Premium Payment calculation. Holders of the Convertible Debentures Series 1 who responded to the solicitation and consented to the amendments received a consent fee equal to 2% of the number of Convertible Debentures Series 1 they held. Consent fees were satisfied through the issuance to the consenting holders of additional Convertible Debentures Series 1, denominated in a principal amount of $1.00 per Convertible Debentures Series 1. Based on the consents received, the Company issued a total of 365,560 consent fee debentures to holders of the Convertible Debentures Series 1.
The following table summarizes the common shares issued by the Company during the nine months ended September 30, 2025 to settle the monthly interest payments for the Convertible Debentures Series 1:
| Interest Period | Number | Amount |
|---|---|---|
| June | 327,756 | $ 145 |
| July | 382,433 | 144 |
| August | 423,118 | 144 |
| Total | 1,133,307 | $ 433 |
On October 1, 2025, the Company issued 310,727 common shares to settle the September 2025 monthly interest, included in accounts payable and accrued liabilities at September 30, 2025 (Note 6), of approximately
Denarius Metals Corp.
Notes to the Interim Condensed Consolidated Financial Statements
September 30, 2025
(Unaudited; Tabular amounts expressed in thousands of U.S. dollars unless otherwise noted)
CA$0.2 million for the Convertible Debentures Series 1. On October 31, 2025, the Company issued 361,572 common shares to settle the October 2025 monthly interest of approximately CA$0.2 million for the Convertible Debentures Series 1.
At any time prior to maturity, the Convertible Debentures Series 1 are convertible at a holder's option into common shares of the Company at a conversion price of CA$0.45 per share (the "2023 Conversion Option"). On May 7, 2025, the Company issued 77,777 common shares on the conversion of CA$35,000 principal amount of Convertible Debentures Series 1.
The Convertible Debentures Series 1 are a financial liability and have been designated at fair value through profit or loss ("FVTPL"). As such, the Convertible Debentures Series 1 were recorded at fair value at inception, being equal to the principal amount, and are subsequently remeasured with the change in fair value being recognized in the statement of operations, except the portion of the change in fair value due to changes in the Company's credit risk, which is recognized in the statement of other comprehensive income ("FVOCI").
The fair value of the Convertible Debentures Series 1 at September 30, 2025 has been determined using the finite-differences method model and level 2 fair value inputs that capture all the features of the Convertible Debentures Series 1, including the 2023 Conversion Option, gold futures curve, Company share price of CA$0.54 per share, share price volatility of 105.94%, risk free interest rate of 2.44%, dividend yield of 0.00% and credit spread of 50.66%. In valuing the Convertible Debentures Series 1, the Company applied a liquidity discount of 28.15% from the Black-Scholes value.
During the three and nine months ended September 30, 2025, the Company recorded a loss on fair value of $6.9 million and $9.7 million, respectively (2024 – fair value losses of $4.7 million and $1.2 million, respectively) related to the Convertible Debentures Series 1 in the statement of operations. The Company also recorded fair value losses of less than $0.1 million and $0.2 million during the three and nine months ended September 30, 2025, respectively (2024 – fair value losses of $0.2 million and $0.2 million in the three and nine months, respectively) related to the change in credit risk associated with the Convertible Debentures Series 1 in the statement of other comprehensive income.
b) Convertible Debentures Series 2
| Number | Amount | |
|---|---|---|
| Issued on closing of first tranche on May 30, 2024 | 10,025,000 | $ 7,329 |
| Issued on closing of second tranche on June 25, 2024 | 3,783,000 | 2,765 |
| Total 2024 Convertible Debenture Units issued | 13,808,000 | 10,094 |
| Value allocated to Convertible Debenture Warrants | - | (1,274) |
| Value allocated to Convertible Debentures Series 2 | 13,808,000 | 8,820 |
| Conversions | (50,000) | (38) |
| Change in FVTPL | - | 2,955 |
| Change in FVOCI due to changes in credit risk | - | (2) |
| Gain on modification of terms | - | (1,264) |
| Issuance of consent fee debentures | 272,460 | 196 |
| Exchange difference | - | (560) |
| As at December 31, 2024 | 14,030,460 | $ 10,107 |
| Conversions | (30,600) | (25) |
| Change in FVTPL | - | 4,724 |
| Change in FVOCI due to changes in credit risk | - | 16 |
| Issuance of consent fee debentures | 272,454 | 266 |
| Exchange difference | - | 314 |
| As at September 30, 2025 | 14,272,314 | $ 15,402 |
In May and June 2024, the Company closed two tranches of a private placement, issuing a total of 13.8 million convertible debenture units ("Convertible Debenture Units") for total gross cash proceeds of CA$13.8 million (equivalent to approximately $10.1 million). The Convertible Debenture Units comprised an aggregate principal amount of CA$13.8 million of senior unsecured convertible debentures (the "Convertible Debentures Series 2") and 6.9 million unlisted warrants (the "Convertible Debenture Warrants") of the Company (Note 12c).
Page | 14
Denarius Metals Corp.
Notes to the Interim Condensed Consolidated Financial Statements
September 30, 2025
(Unaudited; Tabular amounts expressed in thousands of U.S. dollars unless otherwise noted)
The Convertible Debentures Series 2 are non-callable and mature and become payable in full at maturity on May 30, 2030, unless otherwise converted, prepaid or accelerated in accordance with their terms. The Convertible Debentures Series 2 bear interest at 12% per annum, paid monthly in equal installments in cash. At closing in 2024, the Company set aside a portion of the gross proceeds in trust (December 31, 2024 balance - $0.5 million) to fund the monthly interest payments on the Convertible Debentures Series 2 from June 2024 through May 2025.
Commencing June 30, 2026, and at the end of each quarter thereafter, the Company will pay a gold premium in cash on the principal amount of the Convertible Debentures Series 2. The gold premium will be calculated as a percentage equal to 25% of (i) the amount, if any, by which the London P.M. Gold Fix on the quarterly measurement date exceeds $2,000 per ounce (the "2024 Floor Price") divided by (ii) the 2024 Floor Price.
On June 18, 2025, the Convertible Debentures Series 2 were amended through a consent solicitation process to (i) enable the Company to issue common shares rather than cash to settle the monthly interest payments from June 30, 2025 to May 31, 2026, inclusive and (ii) implement a maximum amount of $4,000 per ounce for the London P.M. Gold Fix in the Gold Premium Payment calculation. Holders of the Convertible Debentures Series 1 who responded to the solicitation and consented to the amendments received a consent fee equal to 2% of the number of Convertible Debentures Series 2 they held. Consent fees were satisfied through the issuance to the consenting holders of additional Convertible Debentures Series 2, denominated in a principal amount of $1.00 per Convertible Debentures Series 2. Based on the consents received, the Company issued a total of 272,454 consent fee debentures to holders of the Convertible Debentures Series 2.
The following table summarizes the common shares issued by the Company during the nine months ended September 30, 2025 to settle the monthly interest payments for the Convertible Debentures Series 2:
| Interest period | Number | Amount |
|---|---|---|
| June | 235,384 | $ 103 |
| July | 274,768 | 103 |
| August | 303,999 | 103 |
| Total | 814,151 | $ 309 |
On October 1, 2025, the Company issued 223,006 common shares to settle the September 2025 monthly interest, included in accounts payable and accrued liabilities at September 30, 2025 (Note 6), of approximately CA$0.1 million for the Convertible Debentures Series 2. On October 31, 2025, the Company issued 259,496 common shares to settle the October 2025 monthly interest of approximately CA$0.1 million for the Convertible Debentures Series 2.
At any time prior to maturity, the Convertible Debentures Series 2 are convertible at a holder's option into common shares of the Company at a conversion price of CA$0.60 per share (the "2024 Conversion Option"). On June 19, 2025, the Company issued 25,000 common shares on the conversion of CA$15,000 principal amount of Convertible Debentures Series 2. On September 9, 2025, the Company issued 26,000 common shares on the conversion of CA$15,600 principal amount of Convertible Debentures Series 2.
The Convertible Debentures Series 2 are a financial liability and have been designated at FVTPL. As such, the Convertible Debentures Series 2 were recorded at fair value at inception and are subsequently remeasured with the change in fair value being recognized in the statement of operations, except the portion of the change in fair value due to changes in the Company's credit risk, which is recognized in the statement of other comprehensive income.
The fair value of the liability component of the Convertible Debentures Series 2 at September 30, 2025 has been determined using the finite-differences method model and level 2 fair value inputs that capture all the features of the Convertible Debentures, including the 2024 Conversion Option, gold futures curve, Company share price of CA$0.54 per share, share price volatility of 106.64%, risk free interest rate of 2.49%, dividend yield of 0.00% and credit spread of 50.66%. In valuing the Convertible Debentures Series 2, the Company applied a liquidity discount of 29.05% from the Black-Scholes value.
During the three and nine months ended September 30, 2025, the Company recorded losses on fair value of $3.4 million and $4.7 million, respectively (2024 – fair value losses of $2.2 million and $2.0 million in the three and nine months, respectively), related to the Convertible Debentures Series 2 in the statement of operations.
Page | 15
Denarius Metals Corp.
Notes to the Interim Condensed Consolidated Financial Statements
September 30, 2025
(Unaudited; Tabular amounts expressed in thousands of U.S. dollars unless otherwise noted)
The Company also recorded a loss of approximately $0.1 million and a gain of approximately $0.1 million in the three and nine months ended September 30, 2025, respectively (2024 – fair value gains of less than $0.1 million and less than $0.1 million in the three and nine months, respectively), related to the change in credit risk associated with the Convertible Debentures Series 2 in the statement of other comprehensive income.
9. ZANCUDO NET SMELTER ROYALTY ("NSR") PAYABLE
| As at January 1, 2024 | $ - |
|---|---|
| Issuance of Zancudo NSR, net of transaction costs | 4,734 |
| Accretion | 39 |
| Recognition of a portion of Year 1 Minimum Payment Adjustment | 563 |
| As at December 31, 2024 | $ 5,336 |
| Recognition of the balance of the Year 1 Minimum Payment Adjustment | 187 |
| Settlement of the Year 1 Minimum Payment Adjustment with shares on April 30, 2025 | (750) |
| Accretion (Note 15) | 39 |
| Recognition of a portion of the Year 2 Minimum Payment Adjustment | 376 |
| Total carrying value of the Zancudo NSR payable as at September 30, 2025 | $ 5,188 |
| Less: current portion, represented by the Year 2 Minimum Payment Adjustment recognized | (375) |
| Non-current portion | $ 4,813 |
On March 27, 2024, the Company closed the sale of a 3% NSR on future production from its Zancudo Project to a syndicate of third-party investors for total cash consideration of $5.0 million.
The Zancudo NSR agreement includes a Minimum Payment Adjustment which is calculated on an annual basis, commencing March 31, 2025, until the Zancudo Project reaches commercial production as defined in the Zancudo NSR agreement. The Minimum Payment Adjustment will be paid in cash to the royalty holders and represents the difference between $750,000 and the aggregate amount of actual royalties paid to the royalty holders during the preceding 12-month period. Once commercial production is achieved, the Minimum Payment Adjustment is cancelled.
On April 30, 2025, the Company issued an aggregate of 2,083,500 units to the holders of the Zancudo NSR in exchange for the cancellation of the $750,000 Minimum Payment Adjustment obligation for the first year ended March 31, 2025 ("Year 1"). Each unit consisted of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one common share of the Company at a price of CA$0.60 per common share at any time on or before April 30, 2028.
If commercial production has not been achieved by the Zancudo Project by March 31, 2029, then the Zancudo NSR holders may elect to sell to the Company, and the Company shall be obligated to purchase, the Zancudo NSR for an amount equal to the upfront cash payment totaling $5.0 million (the "Put Option"). Once commercial production has been achieved, the Put Option is cancelled.
This Zancudo NSR obligation has been recognized as a financial liability, initially recorded at the value of the consideration received less transaction costs and subsequently measured at amortized cost. Transaction costs incurred related to the sale of the Zancudo NSR, totalling approximately $0.3 million, have been offset against the fair value of the Zancudo NSR.
10. ZANCUDO PREPAYMENT FACILITY
| As at January 1, 2025 | $ - |
|---|---|
| First advance received | 2,500 |
| Facility fees and expenses | (286) |
| Interest capitalized to principal during the Grace Period (Note 15) | 159 |
| Accretion (Note 15) | 79 |
| Total carrying value of the Zancudo Prepayment Facility as at September 30, 2025 | $ 2,452 |
| Less: current portion | (1,125) |
| Non-current portion | $ 1,327 |
Denarius Metals Corp.
Notes to the Interim Condensed Consolidated Financial Statements
September 30, 2025
(Unaudited; Tabular amounts expressed in thousands of U.S. dollars unless otherwise noted)
In April 2024, the Company signed a commercial agreement with Trafigura Pte. Ltd. ("Trafigura") for the sale at market prices of 100% of the gold-silver concentrates to be produced at its Zancudo Project over the next eight years.
In conjunction with this offtake arrangement, the Company executed a prepayment agreement with Trafigura (the "Zancudo Prepayment Facility") on February 7, 2025 pursuant to which the Company will receive up to a total of $9.0 million from Trafigura in three advances as the Company reaches certain milestones related to construction activities at its Zancudo Project. On February 21, 2025, the Company received the first advance of $2.5 million under the Zancudo Prepayment Facility. Advances under the Zancudo Prepayment Facility bear interest at the three-month Secured Overnight Financing Rate ("SOFR") plus 6% (September 226, 2025 – 10.0%). Interest is being capitalized to the principal amount borrowed under the Zancudo Prepayment Facility during a Grace Period. The principal amount drawn under the Zancudo Prepayment Facility will be repaid, with interest, through equal monthly deductions from amounts payable by Trafigura under the commercial agreement over a 26-month period following the Grace Period. The Zancudo Prepayment Facility is secured by certain assets of the Company related to its Zancudo Project. On signing of the Zancudo Prepayment Facility, the Company issued 3,000,000 common share purchase warrants to Trafigura with an exercise price of CA$0.74 per common share that will expire on February 7, 2028.
In October 2025, the Company received the second advance of $2.5 million from Trafigura under the Zancudo Prepayment Facility following the approval of the Zancudo Project's industrial facility permit from Corantioquia, the local environmental authority in Colombia.
The Zancudo Prepayment Facility has been recognized as a financial liability, initially recorded at fair value and subsequently measured at amortized cost. Facility fees and expenses, including the financing warrants, totaled approximately $1.0 million, of which $0.3 million has been offset against the fair value of the first advance and the balance of $0.7 million is included in deferred financing costs in respect of the future advances from the Zancudo Prepayment Facility. The carrying value of the Zancudo Prepayment Facility will be accreted using an effective interest rate of 17.45%.
11. LEASES
The lease obligations are summarized as follows:
| Maturity | Currency | Interest rate | September 30, 2025 | December 31, 2024 | |
|---|---|---|---|---|---|
| Leases | 2026 | EUR | 8.58% | $ 341 | $ 73 |
| Leases | 2025 | CAD | 7.07% | - | 35 |
| Total lease obligations | 341 | 108 | |||
| Less: current portion | 172 | 87 | |||
| Non-current portion | $ 169 | $ 21 |
The table below summarizes the changes in the lease obligation during the nine months ended September 30, 2025:
| Amount | |
|---|---|
| As at January 1, 2025 | $ 108 |
| Additions | 373 |
| Accretion | 18 |
| Lease payments | (175) |
| Exchange difference | 17 |
| As at September 30, 2025 | $ 341 |
The undiscounted and discounted future lease payments are as follows:
September 30, December 31,
Page | 18
Denarius Metals Corp.
Notes to the Interim Condensed Consolidated Financial Statements
September 30, 2025
(Unaudited; Tabular amounts expressed in thousands of U.S. dollars unless otherwise noted)
| 2025 | 2024 | |
|---|---|---|
| Within one year | $ 194 | $ 89 |
| More than one year | 183 | 21 |
| Total undiscounted lease obligations | 377 | 110 |
| Amount representing interest | (36) | (2) |
| Lease obligations – discounted | $ 341 | $ 108 |
During the nine months ended September 30, 2025, the Company recognized total payments in the consolidated statement of cash flows in the amount of $175,000 (2024 - $208,000).
Scheduled future undiscounted lease payments, comprising principal and interest, are as follows:
| 2025 | 2026 | 2027 | 2028 | Thereafter | Total | |
|---|---|---|---|---|---|---|
| Total payments | $ 49 | $ 194 | $ 67 | $ 28 | $ 39 | $ 377 |
12. SHARE CAPITAL
a) Authorized
Authorized share capital comprises an unlimited number of common shares without par value and 10,000,000 preferred shares at $1.00 par value. No preferred shares have been issued.
b) Issued and fully paid
A summary of the change in the issued and outstanding common shares during the nine-months period ended September 30, 2025 is as follows:
| Shares | Amount | |
|---|---|---|
| Balance, January 1, 2025 | 93,833,066 | $ 116,127 |
| Exercise of Rights Offering Warrants | 141,444 | 76 |
| Exercise of stock options | 50,000 | 29 |
| Shares issued in the 2025 Private Placement | 13,138,000 | 2,676 |
| Shares issued in the LIFE Offering | 12,280,309 | 2,423 |
| Toral Finder's Fee settled in shares | 212,634 | 95 |
| Conversion of Convertible Debentures Series 1 (Note 8a) | 77,777 | 40 |
| Conversion of Convertible Debentures Series 2 (Note 8b) | 51,000 | 25 |
| Settlements of interest on Convertible Debentures (Notes 8a, 8b) | 1,947,458 | 715 |
| Settlement of Zancudo NSR Minimum Payment Adjustment (Note 9) | 2,083,500 | 1,050 |
| Balance, September 30, 2025 | 123,815,188 | $ 123,256 |
2025 Private Placement
On March 20, 2025, the Company completed a non-brokered private placement (the "2025 Private Placement") of 13,138,000 Units at CA$0.50 per Unit for gross proceeds of approximately CA$6.6 million (approximately $4.6 million), of which 3,052,000 Units valued at approximately $1.1 million were issued to settle the Brockville Promissory Notes, including interest (Note 7). Each Unit consisted of one common share and one common share purchase warrant ("2025 Private Placement Warrant). Each 2025 Private Placement Warrant entitles the holder to purchase one common share of the Company at a price of CA$0.60 per common share at any time on or before March 20, 2028.
The aggregate fair value of the Units issued in the 2025 Private Placement amounted to approximately $4.6 million, of which approximately $2.8 million was allocated to the common shares and approximately $1.8 million was allocated to the fair value of the 2025 Private Placement Warrants. Total fair value of the Units issued in the 2025 Private Placement was determined based on the quoted closing price of the Company's common shares and the fair value of the 2025 Private Placement Warrants as described in Note 12c.
Denarius Metals Corp.
Notes to the Interim Condensed Consolidated Financial Statements
September 30, 2025
(Unaudited; Tabular amounts expressed in thousands of U.S. dollars unless otherwise noted)
Transaction costs related to the 2025 Private Placement amounted to approximately $0.1 million, of which $0.1 million was allocated to the common shares and the balance was allocated to the 2025 Private Placement Warrants.
Listed Issuer Financing Exemption ("LIFE") Offering
On June 20, 2025, the Company completed a LIFE Offering of 12,280,309 Units at CA$0.55 per Unit for gross proceeds of approximately CA$6.8 million (approximately $4.9 million). Each Unit consisted of one common share and one common share purchase warrant ("2025 LIFE Offering Warrant). Each 2025 LIFE Offering Warrant entitles the holder to purchase one common share of the Company at a price of CA$0.66 per common share at any time on or before June 20, 2030.
The aggregate fair value of the Units issued in the LIFE Offering amounted to approximately $4.9 million, of which approximately $2.8 million was allocated to the common shares and approximately $2.1 million was allocated to the fair value of the 2025 LIFE Offering Warrants. Total fair value of the Units issued in the LIFE Offering was determined based on the quoted closing price of the Company's common shares and the fair value of the 2025 LIFE Offering Warrants.
Transaction costs related to the LIFE Offering amounted to approximately $0.7 million, of which $0.4 million was allocated to the common shares and the balance was allocated to the 2025 LIFE Offering Warrants. The transaction costs include $0.2 million related to the value of the 859,621 broker warrants issued.
Toral Finder's Fee Shares
In 2022, the Company incurred a finder's fee with an arm's length third party for services rendered in connection with the acquisition of the Toral Project through the initial option arrangement with Europa. The parties agreed to settle the finder's fee through the issuance of a total of 457,163 common shares by the Company (the "Finder's Fee Shares"), of which a total of 244,529 common shares were issued in 2023 as the Company achieved certain milestones under the option agreement. The Finder's Fee Shares were issued at a price of CA$0.63 per share, being the closing price of the shares on the Toronto Stock Venture Exchange on November 22, 2022.
In March 2025, the remaining 212,634 Finder's Fee Shares were issued as a result of the EMI Acquisition (Note 4d) and are subject to a four-month-and-one-day statutory hold period.
c) Share Purchase Warrants
A summary of the change in the share purchase warrants outstanding during the nine-months period ended September 30, 2025 is as follows:
| Outstanding | Common shares issuable | Weighted average exercise price per common share (CA$) | |
|---|---|---|---|
| Balance, January 1, 2025 | 126,164,608 | 57,941,278 | $ 1.59 |
| Warrants issued in the 2025 Private Placement | 13,138,000 | 13,138,000 | 0.60 |
| Warrants issued in the LIFE Offering | 12,280,309 | 12,280,309 | 0.66 |
| Broker warrants issued in the LIFE Offering | 859,621 | 859,621 | 0.66 |
| Warrants issued in settlement of Zancudo NSR Minimum Payment Adjustment (Note 9) | 2,083,500 | 2,083,500 | 0.60 |
| Warrants issued in Zancudo Prepayment Facility financing (Note 10) | 3,000,000 | 3,000,000 | 0.74 |
| Exercise of Rights Offering Warrants (1) | (141,444) | (141,444) | 0.60 |
| Balance, September 30, 2025 | 157,384,594 | 89,161,264 | $ 1.25 |
(1) Cash proceeds from the warrants exercised during the nine months ended September 30, 2025 amounted to CA$84,866.
Page | 19
Denarius Metals Corp.
Notes to the Interim Condensed Consolidated Financial Statements
September 30, 2025
(Unaudited; Tabular amounts expressed in thousands of U.S. dollars unless otherwise noted)
As at September 30, 2025, the Company had the following warrants issued and outstanding:
| Number of warrants | Shares Issuable | Exercise price per share | Expiry date | |
|---|---|---|---|---|
| Listed warrants (Cboe CA: DMET.WT) | 75,000,000 | 7,500,000 | CA$8.00 | March 17, 2026 |
| Unlisted warrants: | ||||
| Finder's warrants | 803,700 | 80,370 | CA$8.00 | March 17, 2026 |
| Rights Warrants | 23,335,676 | 23,335,676 | CA$0.60 | March 2, 2026 |
| 2023 Private Placement Warrants | 16,036,625 | 16,036,625 | CA$0.60 | April 4, 2026 |
| Convertible Debenture Warrants | 6,698,014 | 6,698,014 | CA$0.60 | April 4, 2026 |
| 2024 Private Placement Warrants | 4,149,149 | 4,149,149 | CA$0.85 | October 31, 2026 |
| Zancudo Prepayment Facility warrants | 3,000,000 | 3,000,000 | CA$0.74 | February 7, 2028 |
| 2025 Private Placement Warrants | 13,138,000 | 13,138,000 | CA$0.60 | March 20, 2028 |
| Zancudo NSR Settlement Warrants | 2,083,500 | 2,083,500 | CA$0.60 | April 30, 2028 |
| LIFE Offering Warrants | 12,280,309 | 12,280,309 | CA$0.66 | June 20, 2030 |
| LIFE Offering Broker Warrants | 859,621 | 859,621 | CA$0.66 | June 20, 2030 |
| 157,384,594 | 89,161,264 |
d) Stock option plan
The Company has a stock option plan in place under which it is authorized to grant options to directors, executive officers, management, employees and consultants enabling them to acquire up to a total of 10% of the issued and outstanding common stock of the Company. Under the plan, the option price of any common share in respect of which an option may be granted under the stock option plan shall be fixed by the Board of Directors but shall be not less than the minimum price permitted by Cboe Canada.
As at September 30, 2025, the Company has a total of 10,632,500 stock options outstanding under its stock option plan (December 31, 2024 – 5,992,500).
A summary of the change in the stock options outstanding during the nine months ended September 30, 2025 is as follows:
| Number of stock options outstanding | Weighted average exercise price per common share (CA$) | |
|---|---|---|
| Balance, January 1, 2025 | 5,992,500 | $ 1.46 |
| Granted | 4,700,000 | 0.59 |
| Exercised (1) | (50,000) | 0.52 |
| Cancelled | (10,000) | 4.45 |
| Balance, September 30, 2025 | 10,632,500 | $ 1.08 |
(1) Cash proceeds from options exercised during the nine months ended September 30, 2025 amounted to CA$26,000. The weighted average share price at the date stock options were exercised was CA$0.60.
The table below summarizes information about the stock options outstanding and as at September 30, 2025:
| Expiry date | Stock Options Outstanding | Vested Stock Options | Remaining contractual life in years | Exercise price (CA$/share) |
|---|---|---|---|---|
| June 30, 2026 | 505,000 | 505,000 | 0.7 | $ 4.45 |
| July 25, 2026 | 200,000 | 200,000 | 0.8 | 0.55 |
| November 22, 2026 | 260,000 | 260,000 | 1.1 | 6.50 |
| May 3, 2028 | 3,950,000 | 3,950,000 | 2.6 | 0.52 |
| February 8, 2029 | 200,000 | 200,000 | 3.4 | 0.59 |
| July 11, 2029 | 200,000 | 200,000 | 3.8 | 0.59 |
| April 16, 2030 | 4,700,000 | - | 4.5 | 0.59 |
| August 27, 2030 | 127,500 | 127,500 | 4.9 | 1.00 |
| February 19, 2031 | 490,000 | 490,000 | 5.4 | 4.50 |
| 10,632,500 | 5,932,500 | 3.5 | $ 1.08 |
Denarius Metals Corp.
Notes to the Interim Condensed Consolidated Financial Statements
September 30, 2025
(Unaudited; Tabular amounts expressed in thousands of U.S. dollars unless otherwise noted)
On April 16, 2025, the Company granted a total of 4,700,000 stock options to executive officers, directors, senior management and consultants. During the nine months ended September 30, 2024, the Company granted 200,000 stock options on February 8, 2024 and 200,000 stock options on July 11, 2024 at an exercise price of CA$0.59 per share to two new non-executive directors of the Company.
A summary of the inputs used in the determination of the fair value of the stock options granted during the nine months ended September 30, 2025 and 2024 is as follows:
| Grant date | April 16, 2025 | July 11, 2024 | February 8, 2024 |
|---|---|---|---|
| Number of stock options granted | 4,700,000 | 200,000 | 200,000 |
| Term | 5 years | 5 years | 5 years |
| Vesting | 1 year | 1 year | 1 year |
| Weighted average Black-Scholes option pricing model inputs | |||
| Market price per share | CA$0.59 | CA$0.59 | CA$0.59 |
| Exercise price per share | CA$0.59 | CA$0.59 | CA$0.59 |
| Dividends expected | Nil | Nil | Nil |
| Expected volatility | 102.98% | 104.53% | 98.10% |
| Risk-free interest rate | 2.64% | 3.88% | 4.03% |
| Expected life of options | 5 years | 2.5 years | 2.5 years |
| Fair value per option | $ 0.32 | $ 0.27 | $ 0.25 |
| Share-based compensation recognized in the nine months ended September 30, 2025, including amounts capitalized | $ 696 | $ 27 | $ 5 |
A summary of share-based compensation expense is as follows:
| Three months ended September 30, | Nine months ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Total share-based compensation cost recognized in the period | ||||
| Stock options granted in 2023 | $ - | $ 1 | $ - | $ 313 |
| Stock options granted in 2024 | 1 | 25 | 32 | 38 |
| Stock options granted in 2025 | 386 | - | 696 | - |
| 387 | 26 | 728 | 351 | |
| Less: amounts capitalized to mineral property, plant and equipment and E&E assets (Notes 3, 4) | 66 | - | 120 | 76 |
| Share-based compensation expense | $ 321 | $ 26 | $ 608 | $ 275 |
e) Loss per share
For the three and nine months ended September 30, 2025 and 2024, the stock options and warrants were anti-dilutive.
13. FINANCIAL RISK MANAGEMENT
a) Credit risk
The exposure to credit risk arises through the failure of a third party to meet its contractual obligations to the Company. The Company's exposure to credit risk arises primarily from the Company's cash balances, which are held with highly-rated Canadian, Colombian and Spanish financial institutions.
b) Foreign currency risk
The Company is exposed to foreign currency fluctuations in USD, EUR and COP. Such exposure arises primarily from expenditures that are denominated in currencies other than the functional currency which is denominated in CA. The Company monitors its exposure to foreign currency risks. To reduce its foreign currency exposure associated with operating expenses incurred in USD, EUR and COP, the Company may
Denarius Metals Corp.
Notes to the Interim Condensed Consolidated Financial Statements
September 30, 2025
(Unaudited; Tabular amounts expressed in thousands of U.S. dollars unless otherwise noted)
enter into foreign currency derivatives to manage such risks. For the nine months ended September 30, 2025 and 2024, the Company did not utilize derivative financial instruments to manage this risk.
The following table summarizes, in USD equivalents, the Company's major currency exposure as at September 30, 2025 in USD, EUR and COP arising from foreign currency monetary assets and liabilities and foreign currency components:
| USD | EUR | COP | |
|---|---|---|---|
| Cash | $ 21 | $ 90 | $ 90 |
| Other receivables | - | 68 | 180 |
| Investment in joint venture | - | 11,321 | - |
| Advances to joint venture | - | 2,430 | - |
| Accounts payable and accrued liabilities | (468) | (307) | (1,783) |
| Short-term borrowings | (635) | - | (1,318) |
| Lease obligations | - | (341) | - |
| Other liabilities | - | (303) | - |
| Net financial assets (liabilities) | $ (1,082) | $ 12,958 | $ (2,831) |
Based on the net exposure at September 30, 2025, a 10% depreciation or appreciation of the USD against the CA would result in a $98,000 increase or decrease in the Company's after-tax net loss and a 10% depreciation or appreciation of the EUR and COP against the CA would result in a $1,178,000 and $257,000 decrease or increase, respectively in the Company's other comprehensive loss.
c) Liquidity risk
The Company manages its liquidity risk by continuously monitoring forecast cash flow requirements. As at September 30, 2025, the Company has cash and cash equivalents of approximately $1.0 million. As such, cash inflows are dependent on the Company's ability to develop its mineral property and E&E assets, obtain financing through the issuance of additional securities, entering into debt or credit facilities, or entering into joint ventures, partnerships or other similar arrangements.
The Company's undiscounted commitments as at September 30, 2025 consist of the following:
| Less than 1 year | 1 to 3 years | 4 to 5 years | Over 5 years | Total | |
|---|---|---|---|---|---|
| Accounts payable and accrued liabilities (Note 6) (1) | $ 4,120 | $ 1,054 | $ 268 | $ - | $ 5,442 |
| Short-term borrowings (Note 7) | 2,254 | - | - | - | 2,254 |
| Convertible Debentures (Note 8) (2) | - | - | 24,540 | - | 24,540 |
| Zancudo NSR liability (Note 9) (3) | 750 | 1,500 | 5,750 | - | 8,000 |
| Zancudo Prepayment Facility (Note 10) (4) | 1,058 | 1,442 | - | - | 2,500 |
| Lease obligations (Note 11) | 194 | 129 | 48 | 6 | 377 |
| Other liabilities | 25 | 100 | 100 | 78 | 303 |
| Total | $ 8,401 | $ 4,225 | $ 30,706 | $ 84 | $ 43,416 |
(1) Includes an amount payable related to the acquisition of the CRI assets which is being paid over a four-year period and is carried at a discounted amount at September 30, 2025.
(2) Represents the principal amount of the Convertible Debentures as at September 30, 2025 due at maturity.
(3) Represents the annual Minimum Payment Adjustment obligation and the Put Option, both of which are cancelled once the Zancudo Project attains commercial production.
(4) Represents the principal amount of the first advance drawn under the Zancudo Prepayment Facility.
d) Fair value risk
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.
For financial instruments that are recognized at fair value on a recurring basis, the Company determines whether transfers have occurred between levels in the hierarchy by re-assessing their classification (based on the lowest level input that is significant to the fair value measurement as a whole) at the end of each reporting period. The fair values of cash and cash equivalents, cash in trust, other receivables and accounts
Denarius Metals Corp.
Notes to the Interim Condensed Consolidated Financial Statements
September 30, 2025
(Unaudited; Tabular amounts expressed in thousands of U.S. dollars unless otherwise noted)
payable and accrued liabilities approximate their carrying values due to the short-term maturity of these financial instruments.
e) Capital management
The Company's objectives, when managing capital, are to safeguard cash as well as maintain financial liquidity and flexibility in order to preserve its ability to meet financial obligations and deploy capital to maintain investor, creditor and market confidence to sustain the future development of the business. The Company considers its capital structure to include equity attributable to its shareholders of $40.2 million (December 31, 2024 – $39.7 million).
The Company's financial strategy is designed to maintain a flexible capital structure consistent with the objectives stated above and to respond to business growth opportunities and changes in economic conditions. In order to maintain or adjust its capital structure, the Company may, from time to time, issue new shares, issue new debt (secured, unsecured, convertible and/or other types of debt instruments), acquire or dispose of assets or adjust its capital spending to manage its ability to continue as a going concern. The Company is not subject to any externally imposed capital requirements.
- REVENUE
| Three months ended September 30, | Nine months ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Gold | $ 392 | $ - | $ 436 | $ - |
| Silver | 64 | - | 69 | - |
| $ 456 | $ - | $ 505 | $ - |
- FINANCE COSTS
| Three months ended September 30, | Nine months ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Convertible Debentures interest expense (Notes 8a, 8b) | $ 740 | $ 696 | $ 2,176 | $ 1,702 |
| Zancudo NSR Minimum Payment Adjustment (Note 9) | 188 | 187 | 563 | 375 |
| Accretion of Zancudo NSR liability (Note 9) | 13 | 13 | 39 | 26 |
| Interest on Zancudo Prepayment Facility (Note 10) | 66 | - | 159 | - |
| Accretion of Zancudo Prepayment Facility (Note 10) | 40 | - | 79 | - |
| Interest on Brockville Promissory Notes (Note 7) | 7 | - | 35 | - |
| Interest on Zenk Promissory Note (Note 7) | 18 | - | 25 | - |
| Interest on other short-term borrowing facilities (Note 7) | 43 | - | 150 | - |
| Total borrowing costs | 1,115 | 896 | 3,226 | 2,103 |
| Less: amount capitalized to mineral property (Note 3) | (790) | - | (1,817) | - |
| Net borrowing costs expensed | 325 | 896 | 1,409 | 2,103 |
| Accretion of amount payable related to acquisition of CRI assets | 37 | 53 | 125 | 77 |
| Accretion of amount payable related to acquisition of RNR (Note 5) | - | 847 | - | 3,026 |
| Accretion of lease obligations (Note 11) | 7 | 2 | 18 | 15 |
| Convertible Debentures Series 2 issue costs | - | 25 | - | 303 |
| Convertible Debentures consent fees | - | - | 761 | - |
| Convertible Debentures consent solicitation costs | 14 | - | 77 | - |
| Other financing costs | 4 | - | 64 | - |
| $ 387 | $ 1,823 | $ 2,454 | $ 5,524 |
The weighted average rate used to calculate the capitalized interest on the general borrowings was 12%.
Page | 23
Denarius Metals Corp.
Notes to the Interim Condensed Consolidated Financial Statements
September 30, 2025
(Unaudited; Tabular amounts expressed in thousands of U.S. dollars unless otherwise noted)
16. EXPENSES BY NATURE
During the three and nine months ended September 30, 2025, general and administrative expenses included $0.4 million and $1.3 million, respectively, of salaries and other employee benefits (2024 - $0.4 million and $1.1 million, respectively).
17. SEGMENT DISCLOSURES
The Company's reportable segments are consistent with the Company's geographic regions in which the Company's projects are located. In determining the Company's segment structure, the Company considered the basis on which the chief operating decision-maker reviews the financial and operational performance and whether any of the Company's exploration operations share similar economic, operational and regulatory characteristics. The Company considers its Zancudo Project and Phosphates Project in Colombia, its Lomero Project, Toral Project and joint venture in Spain and its corporate functions in Canada as its reportable segments.
The following table shows the Company's reportable segments and its geographic locations:
| Colombia | Spain | Corporate | Total | |
|---|---|---|---|---|
| Nine months September 30, 2025 | ||||
| Net loss | $ (1) | $ (373) | $ (20,547) | $ (20,921) |
| Capital expenditures (Notes 3 and 4) | 3,124 | 2,271 | - | 5,395 |
| As at September 30, 2025 | ||||
| Total assets | $ 30,197 | $ 70,449 | $ 1,044 | $ 101,690 |
| Total liabilities | 11,446 | 2,258 | 47,748 | 61,452 |
| Nine months September 30, 2024 | ||||
| Net loss | $ (174) | $ (3,804) | $ (8,076) | $ (12,054) |
| Capital expenditures | 9,730 | 2,355 | - | 12,085 |
| As at December 31, 2024 | ||||
| Total assets | $ 21,227 | $ 58,213 | $ 1,613 | $ 81,053 |
| Total liabilities | 8,337 | 2,280 | 30,763 | 41,380 |